The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids
Pharmaceutics · 31.08.2023 · 15 (9) · 2264
DOI: 10.3390/pharmaceutics15092264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 31.08.2023. Verfasst von Nkune Williams Nkune und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, P.O. Box 17011, Johannesburg 2028, South Africa. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa, the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa, the University of Johannesburg.
Abstract (Originalsprache)
Melanoma remains a major public health concern that is highly resistant to standard therapeutic approaches. Photodynamic therapy (PDT) is an underutilised cancer therapy with an increased potency and negligible side effects, and it is non-invasive compared to traditional treatment modalities. Three-dimensional multicellular tumour spheroids (MCTS) closely resemble in vivo avascular tumour features, allowing for the more efficient and precise screening of novel anticancer agents with various treatment combinations. In this study, we utilised A375 human melanoma spheroids to screen the phototoxic effect of zinc phthalocyanine tetrasulfonate (ZnPcS4) conjugated to gold nanoparticles (AuNP). The nanoconjugate was synthesised and characterised using ultraviolet-visible spectroscopy, a high-resolution transmission electron microscope (TEM), dynamic light scattering (DLS), and zeta potential (ZP). The phototoxicity of the nanoconjugate was tested on the A375 MCTS using PDT at a fluency of 10 J/cm2. After 24 h, the cellular responses were evaluated via microscopy, an MTT viability assay, an ATP luminescence assay, and cell death induction using annexin propidium iodide. The MTT viability assay demonstrated that the photoactivated ZnPcS4, at a concentration of 12.73 µM, caused an approximately 50% reduction in the cell viability of the spheroids. When conjugated to AuNPs, the latter significantly increased the cellular uptake and cytotoxicity in the melanoma spheroids via the induction of apoptosis. This novel Zinc Phthalocyanine Nanoconjugate shows promise as a more effective PDT treatment modality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, P.O. Box 17011, Johannesburg 2028, South Africa.
ORCID-Profile: Nkune Williams Nkune, Heidi Abrahamse
Förderung
- South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa
- the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa
- the University of Johannesburg
- the National Laser Centre
- the National Research Foundation—South African Research Chairs Initiative (NRF-SARCHI)
Zitieren
APA
Nkune, N. W., & Abrahamse, H. (2023). The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids. Pharmaceutics, 15(9), 2264. https://doi.org/10.3390/pharmaceutics15092264
Vancouver
Nkune NW, Abrahamse H. The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids. Pharmaceutics. 2023;15(9):2264. doi:10.3390/pharmaceutics15092264
BibTeX
@article{Nkune2023,
author = {Nkune, Nkune Williams and Abrahamse, Heidi},
title = {The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2264},
doi = {10.3390/pharmaceutics15092264}
}
EUVIMED